Trastuzumab deruxtecan
Cat. No.: A125
Featured
Chemical Structure
1826843-81-5
We are official vendor of:
More than 5000 active chemicals with high quality for research!
Field of application
Trastuzumab deruxtecan (DS-8201a) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab deruxtecan is composed of a humanized anti-HER2 antibody, an enzymatically cleavable peptide-linker, and a topoisomerase I inhibitor. Trastuzumab deruxtecan can be used for the research of HER2-positive breast cancer and gastric cancer.
| Cas No.: |
1826843-81-5 |
| pH value: |
Corresponds to reference standard: PASS |
| Non-reduced CE-SDS: |
>95% |
| SEC-HPLC: |
>95% |
| Isoelectric Point: |
Corresponds to reference standard |
| Osmolality: |
Corresponds to reference standard: PASS |
| Peptide mapping: |
Corresponds to reference standard: PASS |
| N-terminal sequence: |
Corresponds to reference standard: PASS |
MSDS
| TITLE |
DOWNLOAD |
| MSDS_33307_DC49408_1826843-81-5 |
|
COA
| LOT NO. |
DOWNLOAD |
|
|
Get Quote
